Brief: Lava Therapeutics Reports Fourth Quarter And Year-End 2022 Results

LAVA Therapeutics NV

11/04/2023 13:44

April 11 (Reuters) - LAVA Therapeutics NV  LVTX.O :
    * LAVA THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS
FOURTH
QUARTER AND YEAR-END 2022 FINANCIAL RESULTS
    * LAVA THERAPEUTICS NV - BALANCE SHEET WITH CASH AND
INVESTMENTS
OF $132.9 MILLION AS OF DECEMBER 31, 2022, EXPECTED TO PROVIDE
CASH RUNWAY INTO 2026
    * LAVA THERAPEUTICS NV QTRLY NET LOSS PER SHARE, BASIC AND
DILUTED
$0.57
    * LAVA THERAPEUTICS NV - RESEARCH AND LICENSE REVENUE WAS
$2.6
MILLION AND $1.1 MILLION FOR QTRS ENDED DEC 31, 2022 AND 2021,
RESPECTIVELY

Source text for Eikon:  ID:nGNXb7FJYW 
Further company coverage:  LVTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))